Evidence map›Paper›PMID 35602813›Full record

ReviewCureus2022

Outcomes With Left Ventricular Assist Device in End-Stage Renal Disease: A Systematic Review.

Sofia Lakhdar, Mahmoud Nassar, Chandan Buttar, Laura M Guzman Perez, Shahzad Akbar, Anoosh Zafar, Most Munira

Abstract readReview
In one paragraph

Review in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sofia LakhdarInternal Medicine, Queens Hospital Center, New York City, USA.
Mahmoud NassarInternal Medicine, Icahn School of Medicine at Mount Sinai, New York City Health and Hospitals/Queens, New York City, USA.
Chandan ButtarInternal Medicine, Icahn School of Medicine at Mount Sinai, New York City Health and Hospitals/Queens, New York City, USA.
Laura M Guzman PerezInternal Medicine, Icahn School of Medicine at Mount Sinai, Queens Hospital Center, New York City, USA.
Shahzad AkbarInternal Medicine, Kettering Medical Center, Dayton, USA.
Anoosh ZafarMedicine, Rawal Institute of Health Sciences, Islamabad, PAK.
Most MuniraCardilogy/Medicine, Weill Cornell Medicine, New York City, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Renal dysfunction is a common comorbidity in patients with advanced heart failure who may benefit from mechanical circulatory support (MCS). Unfortunately, renal function may result after left ventricular assist device (LVAD) implantation. The purpose of this study is to examine the outcomes of advanced heart failure patients with end-stage renal disease (ESRD) requiring mechanical circulatory support as a bridge to transplant (BTT) or destination therapy (DT). We searched Medline, Embase, and Cochrane in September 2021. The following keywords were used: left ventricular assist device or LVAD and end-stage renal disease or ESRD. Our study included case reports, case series, descriptive studies, and randomized control trials. Review articles, guidelines, systematic reviews, and meta-analyses were excluded. We also excluded pediatric cases. We identified 278 articles; 92 were duplicated, 186 articles entered the screening phase, and 133 articles were excluded by title and abstract. After the full-text screening, 40 articles were excluded. This systematic review included 13 articles. Among the contraindications to LVAD implantation, a general contraindication is for patients found to have stage 4 chronic kidney disease (CKD) (estimated glomerular filtration rate (eGFR): <30 mL/minute/1.73 m

Indexed as

advanced heart failurebridge to transplantchronic kidney disease (ckd)destination therapyend-stage renal dysfunctionheart assist deviceshemodialysisventricular assist device

Identifiers

PMID35602813
PMCPMC9117860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.